NVOvsSNY
Novo-Nordisk A/SvsSanofi American Depositary Shares (Each representing one-half of one ordinary share). Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Novo-Nordisk A/S
$38.52
-21.32%
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
$47.53
-0.96%
60-day price, rebased to 100
Round-by-round
Valuation upside
+621.40% vs +29.90% to DCF fair value
Balance-sheet strength
Altman Z 2.05 vs 1.86
Fundamental quality
Piotroski 5.00 vs 7.00 (of 9)
Growth + margins
Rule-of-40 15.80 vs 20.90
60-day momentum
-35.18% vs +0.08% price return
Market-cap liquidity
$171.1B vs $111.6B
Verdict
Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onNVOorSNY
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.